Insider · CIK 0001184334

CONWAY ROBERT E

Reports to the SEC for 3 companies · BOULDER, CO

sec.gov

Transactions

Companies

Filings

CIK

0001184334

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,650 sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,912 sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,650 sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,650 sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17.5K sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,650 sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−50K sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,868 sh	—	—	0
2024-05-20	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,075 sh	—	—	0
2024-01-30	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Chairman of the Board	AAward	+6,000 sh	—	—	6,000
2024-01-02	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2023-01-03	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2022-12-15	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Chairman of the Board	AAward	+6,000 sh	—	—	6,000
2022-01-03	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-09-23	ALPINE IMMUNE SCIENCES, INC.P Purchase	Director	PPurchase	+15K sh	$10.08	+$151K	50,000
2021-09-23	ALPINE IMMUNE SCIENCES, INC.S Sale	Director	SSale	+15K sh	$10.08	+$151K	50,000
2021-09-21	ALPINE IMMUNE SCIENCES, INC.P Purchase	Director	PPurchase	+10K sh	$9.80	+$98K	35,000
2021-05-12	ORKAOruka Therapeutics, Inc.P Purchase	Director, Chairman of the Board	PPurchase	+10K sh	$3.19	+$31.9K	50,000
2021-05-05	ORKAOruka Therapeutics, Inc.P Purchase	Director, Chairman of the Board	PPurchase	+10K sh	$3.23	+$32.3K	40,000
2021-01-12	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Chairman of the Board	AAward	+12K sh	—	—	12,000
2021-01-04	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award	Director	AAward	+7,650 sh	—	—	7,650
2020-12-18	ORKAOruka Therapeutics, Inc.P Purchase	Director, Chairman of the Board	PPurchase	+10K sh	$4.16	+$41.6K	30,000
2020-11-19	ALPINE IMMUNE SCIENCES, INC.P Purchase	Director	PPurchase	+10K sh	$8.03	+$80.3K	25,000
2020-09-25	ORKAOruka Therapeutics, Inc.P Purchase	Director, Chairman of the Board	PPurchase	+5,000 sh	$4.28	+$21.4K	20,000
2020-09-22	ORKAOruka Therapeutics, Inc.P Purchase	Director, Chairman of the Board	PPurchase	+3,056 sh	$4.66	+$14.2K	15,000
2020-09-21	ORKAOruka Therapeutics, Inc.P Purchase	Director, Chairman of the Board	PPurchase	+10K sh	$4.77	+$47.7K	11,944
2020-01-02	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award	Director	AAward	+7,650 sh	—	—	7,650
2019-01-02	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award	Director	AAward	+7,650 sh	—	—	7,650
2018-03-01	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Chairman of the Board	AAward	+8,000 sh	—	—	8,000
2018-01-02	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award	Director	AAward	+7,650 sh	—	—	7,650
2017-07-14	ORKAOruka Therapeutics, Inc.P Purchase	Director, Chairman of the Board	PPurchase	+10K sh	$2.49	+$24.9K	35,000
2017-05-09	ALPINE IMMUNE SCIENCES, INC.P Purchase	Director	PPurchase	+5,000 sh	$2.34	+$11.7K	45,000
2017-05-08	ALPINE IMMUNE SCIENCES, INC.P Purchase	Director	PPurchase	+15K sh	$2.28	+$34.2K	60,000
2017-05-05	ALPINE IMMUNE SCIENCES, INC.P Purchase	Director	PPurchase	+20K sh	$2.30	+$46K	40,000
2017-05-04	ALPINE IMMUNE SCIENCES, INC.P Purchase	Director	PPurchase	+10K sh	$2.26	+$22.6K	20,000
2017-03-24	ORKAOruka Therapeutics, Inc.P Purchase	Director, Chairman of the Board	PPurchase	+25K sh	$2.59	+$64.8K	25,000
2017-02-16	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Chairman of the Board	AAward	+8,000 sh	—	—	8,000
2016-09-12	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to Buy)A Award	Director	AAward	+12.3K sh	—	—	12,300
2016-02-11	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Chairman of the Board	AAward	+8,000 sh	—	—	8,000
2015-12-09	ALPINE IMMUNE SCIENCES, INC.P Purchase	Director	PPurchase	+10K sh	$8.10	+$81K	10,000
2015-09-11	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to Buy)A Award	Director	AAward	+7,650 sh	—	—	7,650
2015-07-16	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to Buy)A Award	Director	AAward	+11.5K sh	—	—	11,475
2015-02-12	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Chairman of the Board	AAward	+8,000 sh	—	—	8,000
2014-02-11	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Chairman of the Board	AAward	+8,000 sh	—	—	8,000
2013-09-17	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Chairman of the Board	AAward	+14.8K sh	—	—	14,750
2013-09-17	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Chairman of the Board	AAward	+2,608 sh	—	—	2,608
2011-10-04	ARRAY BIOPHARMA INCA Award	Director, CEO	AAward	+57.2K sh	—	—	633,386
2011-06-17	ARRAY BIOPHARMA INCP Purchase	Director, CEO	PPurchase	+25K sh	$2.17	+$54.3K	576,196

Recent filings

Accepted (ET)
May 204
CONWAY ROBERT E0001626199-24-000098
SEC(opens sec.gov)
Jan 314
CONWAY ROBERT E0001209191-24-002478
SEC(opens sec.gov)
Jan 44
CONWAY ROBERT E0001626199-24-000014
SEC(opens sec.gov)
Jan 54
CONWAY ROBERT E0001626199-23-000016
SEC(opens sec.gov)
Dec 194
CONWAY ROBERT E0001209191-22-061901
SEC(opens sec.gov)
Jan 44
CONWAY ROBERT E0001626199-22-000012
SEC(opens sec.gov)
Sep 274/A
CONWAY ROBERT E0001626199-21-000130
SEC(opens sec.gov)
Sep 244
CONWAY ROBERT E0001626199-21-000127
SEC(opens sec.gov)
Sep 234
CONWAY ROBERT E0001626199-21-000120
SEC(opens sec.gov)
May 134
CONWAY ROBERT E0001209191-21-032381
SEC(opens sec.gov)

Companies

Address

3200 WALNUT STREET

BOULDER, CO, 80301